STERIS plc

Listed Company

STECIK 0001757898NYSELarge AcceleratedOrthopedic, Prosthetic & Surgical Appliances & SuppliesL2FY ends Mar 31

Period

FY 2026

Revenue

$5.94B

Net Income

$782.30M

Total Assets

$10.74B

Equity

$7.18B

Shares Out

97.60M

Op. Cash Flow

$1.34B

STE$217.82−2.97% · past yearDBEQ Basic

Daily closing prices

Business

STERIS plc is a global provider of products and services for infection prevention, supporting patient care across healthcare and life-science sectors. The company offers consumable products (detergents, endoscopy accessories, barrier products, instruments), capital equipment (sterilizers, surgical tables, automated endoscope reprocessors), and services (equipment installation and maintenance, microbial reduction, instrument repair, laboratory testing, outsourced reprocessing, OR integration). STERIS operates through three reportable segments: Healthcare (sterile processing and procedural support for hospitals and surgery centers), Applied Sterilization Technologies (contract sterilization and laboratory testing for medical device and pharmaceutical manufacturers), and Life Sciences (aseptic manufacturing support with consumables, equipment, and maintenance services).

Summary from 10-K filed 2026-05-29

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Total revenues	5,936	5,460	5,139	4,536	4,223
Cost of revenues	3,309	3,057	2,921	2,556	2,340
Gross Profit	2,627	2,403	2,218	1,981	1,883
Selling, general, and administrative	1,408	1,334	1,252	1,091	1,318
Research and development	113	108	104	98	87
Litigation Settlement, Loss	0	48	0	0	—
Restructuring Costs	4	46	26	485,000	48,000
Total operating expenses	1,525	1,536	1,382	1,190	1,405
Income (loss) from operations	1,102	867	836	791	478
Interest expense	61	86	144	108	—
Interest income and miscellaneous expense	−10	−8	−11	3	−6
Other expense (income), net	−4	7	0	0	—
Total non-operating expenses, net	54	70	133	111	111
Income (loss) before income tax expense (benefit)	1,047	796	703	680	367
Income tax expense (benefit)	262	185	150	124	82
Income from continuing operations, net of income tax	785	612	553	556	284
Income (loss) from discontinued operations, net of income tax	0	5	−173	−450	−42
Net income	785	616	380	106	243
Less: Net income attributable to noncontrolling interests	3	1	2	−1	−1
Net income attributable to shareholders	782	615	378	107	244
Income (Loss) from Continuing Operations, Per Basic Share	7.97	6.19	5.58	5.59	2.93
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	0	0.05	−1.75	−4.52	−0.43
Earnings Per Share, Basic	7.97	6.24	3.83	1.07	2.5
Income (Loss) from Continuing Operations, Per Diluted Share	7.93	6.16	5.55	5.56	2.9
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	0	0.05	−1.74	−4.49	−0.42
Earnings Per Share, Diluted	7.93	6.2	3.81	1.07	2.48
Cash dividends declared per common share outstanding	2.46	2.23	2.03	1.84	1.69

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Cash and cash equivalents	440	172	207	208	348
Accounts receivable (net of allowances of $24,354 and $22,984, respectively)	1,093	1,044	1,008	865	799
Inventories, net	632	581	675	604	575
Prepaid expenses and other current assets	230	204	174	176	157
Total current assets	2,395	2,001	2,869	2,011	1,879
Property, plant, and equipment, net	2,161	1,957	1,765	1,633	1,553
Operating Lease, Right-of-Use Asset	155	156	173	167	188
Goodwill	4,195	4,096	4,071	3,879	3,939
Intangible Asset, Excluding Goodwill, after Accumulated Amortization	1,620	1,854	2,119	2,077	3,329
Other assets	211	83	66	78	71
Assets	10,737	10,147	11,064	10,822	11,424
Accounts payable	339	281	252	264	226
Accrued Income Taxes, Current	29	22	14	40	27
Accrued payroll and other related liabilities	221	193	165	118	184
Capital Lease Obligations, Current	36	34	31	30	36
Short-term Debt	119	125	86	60	143
Accrued expenses and other	402	368	320	298	307
Total current liabilities	1,145	1,022	931	862	922
Long-term indebtedness	1,813	1,919	3,120	3,019	2,945
Deferred income taxes, net	391	404	480	618	781
Capital Lease Obligations, Noncurrent	120	125	146	140	155
Other Liabilities, Noncurrent	72	62	72	76	76
Total liabilities	3,540	3,531	4,748	4,735	4,879
Commitments and contingencies (see note 10)	—	—	—	—	—
Ordinary shares, with $0.001 par value; 500,000 shares authorized; 98,301 and 98,883 ordinary shares issued and outstanding, respectively	4,281	4,420	4,543	4,486	4,743
Retained earnings	3,016	2,475	2,088	1,912	1,999
Accumulated other comprehensive income	−113	−292	−329	−321	−210
Total shareholders' equity	7,184	6,603	6,302	6,077	6,532
Noncontrolling interest	14	12	13	10	12
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	7,197	6,616	6,315	6,087	6,545
Total liabilities and equity	10,737	10,147	11,064	10,822	11,424

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Depreciation, depletion, and amortization	487	476	565	553	553
Deferred income taxes	−17	−77	−131	−186	−107
Share-based compensation	62	57	57	39	58
Loss on the disposal of property, plant, equipment, and intangibles, net	4	6	25	22	15
Loss on classification as held for sale	0	0	206	0	0
Gain (Loss) on Disposition of Business And Equity Investments, Net	−300,000	6	300,000	−67,000	—
Amortization of inventory fair value adjustments	0	0	5	7	67
Other items	−6	−4	12	−25	−22
Accounts receivable, net	−25	−29	−128	−133	−52
Inventories, net	−24	73	−38	−124	−103
Other current assets	−23	−50	−2	−24	7
Accounts payable	51	34	−19	53	15
Accruals and other, net	48	39	40	−22	−16
Net cash provided by operating activities	1,341	1,148	973	757	685
Purchases of property, plant, equipment, and intangibles, net	−369	−370	−360	−362	−288
Proceeds from the sale of property, plant, equipment, and intangibles	11	9	7	15	2
Proceeds from Divestiture of Businesses	0	815	10	7	170
Proceeds from Sale of Other Investments	0	0	4	0	0
Payments to Acquire Investments	−134	−11	−2	0	0
Investments in businesses, net of cash acquired	−20	−54	−546	−43	−550
Net cash used in investing activities	−513	389	−887	−383	−667
Repayments of Secured Debt	0	−638	−60	−157	−345
Payments for Repurchase of Private Placement	−125	−80	0	−91	−721
Proceeds Under Credit Facility, net	3	−446	182	242	−190
Amortization of Financing Costs	0	−2	0	0	−17
Payments of Merger Related Costs, Financing Activities	−400,000	−400,000	−6	−1	−33
Repurchases of ordinary shares	−236	−211	−12	−309	−56
Cash dividends paid to common shareholders	−242	−220	−201	−183	−163
Payments to Noncontrolling Interests	−1	−2	−2	−794,000	−997,000
Proceeds from Noncontrolling Interests	0	3	3	0	4
Proceeds from (Payment for) Other Financing Activity	33	26	11	2	10
Net cash (used in) provided by financing activities	−568	−1,572	−85	−499	116
Effect of exchange rate changes on cash and cash equivalents	7	200,000	−2	−15	−6
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	268	−35	−1	−140	128

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is STERIS plc's CIK number?

STERIS plc's SEC CIK number is 0001757898 (1757898). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find STERIS plc's SEC filings?

All of STERIS plc's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did STERIS plc last report earnings?

STERIS plc (STE) most recently filed an earnings 8-K with the SEC on May 11, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-033580). This is STERIS plc's most recent earnings filing of record — not a forecast of its next earnings date.

What is STERIS plc's most recent earnings 8-K?

STERIS plc's latest earnings 8-K (Item 2.02) was filed May 11, 2026 under accession 0001628280-26-033580. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View STERIS plc's latest earnings 8-K →
Look up any company's CIK number →